פרימקור זריקות
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MILRINONE
Available from:
SANOFI ISRAEL LTD
ATC code:
C01CE02
Pharmaceutical form:
תמיסה להזרקה
Composition:
MILRINONE 1 MG/ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
DELPHARM DIJON, FRANCE
Therapeutic group:
MILRINONE
Therapeutic area:
MILRINONE
Therapeutic indications:
For the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. For the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.
Authorization date:
2022-11-30
